Clinical Heterogeneity and Transitions of Obesity in Mexico
Authors' conclusion
The prevalence of obesity comorbidities has been stable over time in Mexico but increases with age. The rising prevalence of obesity and the aging of the population will cause additional burdens to the population and the health system.
Study context
- Population
- Adults with obesity in Mexico, ENSANUT health and nutrition surveys 2006–2022analysed
- Participants
- 20,758 adults
- Outcome
- Prevalence of obesity-associated comorbidities (diabetes, dyslipidemia, hypertension, depression, impaired mobility) per EOSS dimensions, by sex and age groups
- Follow-up
- 2006 to 2022
Methodological detailsnationally representative surveys (ENSANUT) 2006–2022
- Nationally representative surveys (ENSANUT) 2006–2022
Main finding
As reported in the abstract
Most prevalent EOSS categories
Edmonton Obesity Staging System (EOSS) medical dimension stage 2
90.1%
EOSS functional dimension stage 1
75.1%
EOSS mental dimension stage 1
62.9%
Observational data: associations, not effects.
Further findings
Mean body mass index (BMI) across survey rounds · 2006 to 2022
- Mean BMI increased progressively at all ages
- from 30.2 to 31.0
Metabolically healthy obesity (MHO)
- Depression and impaired mobility highly prevalent even among MHO individuals
- In both sexes, MHO less likely as age and BMI increased
- MHO: absence of diabetes, dyslipidemia and hypertension
Original publication
Clinical Heterogeneity and Transitions of Obesity in Mexico. J Clin Endocrinol Metab. Published 11 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →